Well Told Grants

Federal grant recipients / New York

Federal grants to Fesariustherapeutics Inc

New York, New York · Small businesses · UEI YTNJCJM8KS58

Fesariustherapeutics Inc in New York, New York received $4.3 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Arthritis, Musculoskeletal and Skin Diseases Research, with $3.6 million. In fiscal 2025 it was awarded $349,892.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Fesariustherapeutics Inc by fiscal year
Fiscal yearAwardsAmount
FY 20211$914,554
FY 20220$0
FY 20232$1.3 million
FY 20243$1.7 million
FY 20251$349,892

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Fesariustherapeutics Inc

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Arthritis, Musculoskeletal and Skin Diseases Research 93.8463$3.6 million
Biomedical Research and Research Training 93.8592$699,237

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services5$4.3 million

Largest awards

The 5 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
An advanced dermal regeneration scaffold for reconstructive surgery - project summary/abstract due to the inability of the dermis to regenerate on its own, large full thickness skin loss cannot be restored naturally. The current gold standard treatment involves autologous tissue transfer in which th
ASST_NON_R44AR082787_075 on USAspending
Arthritis, Musculoskeletal and Skin Diseases ResearchAugust 4, 2023$1.9 million
Dermisphere????????????: an advanced dermal regeneration scaffold for reconstructive surgery, phase II
ASST_NON_R44AR076301_075 on USAspending
Arthritis, Musculoskeletal and Skin Diseases ResearchAugust 19, 2021$914,554
Dermisphere?: an advanced dermal regeneration scaffold for reconstructive surgery, crp - project summary/abstract due to the inability of the dermis to regenerate on its own, large full thickness skin loss cannot be restored naturally. The current gold standard treatment involves autologous tissue t
ASST_NON_SB1AR076301_075 on USAspending
Arthritis, Musculoskeletal and Skin Diseases ResearchAugust 15, 2023$796,397
An antimicrobial dermal regeneration template for application in challenging wound environments - project summary/abstract successful and definitive closure of a wound is often jeopardized by microbial contamination or even colonization, particularly in patients requiring surgical treatment of traum
ASST_NON_R43GM161193_075 on USAspending
Biomedical Research and Research TrainingJuly 31, 2025$349,892
An advanced dermal regeneration scaffold for skin loss due to burn wounds - abstract the gold standard treatment for large full thickness skin loss (FTSL) due to burns involves autologous tissue transfer in which the patient serves as their own donor. However, such treatment may be challenging due t
ASST_NON_R43GM156172_075 on USAspending
Biomedical Research and Research TrainingAugust 13, 2024$349,345

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Fesariustherapeutics Inc get?

$4.3 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Fesariustherapeutics Inc the most?

The Department of Health and Human Services, with $4.3 million in 5 awards.

What is Fesariustherapeutics Inc's largest federal grant?

$1.9 million under Arthritis, Musculoskeletal and Skin Diseases Research, with its first action in the period on August 4, 2023. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Fesariustherapeutics Inc?

Its largest are Arthritis, Musculoskeletal and Skin Diseases Research and Biomedical Research and Research Training.

Other grant recipients in New York

Largest federal grant recipients in New York · Federal grants in New York